DCOY Decoy Therapeutics Inc.: institutional ownership and insider trading
5 funds reported holding $31.3K of Decoy Therapeutics Inc. in their latest 13F filings; in Q2 2026 funds net bought $19.5K, with 2 new positions and 2 funds selling out; over the last 12 months insiders bought $19.8K and sold $18 on the open market.
Largest institutional holders of DCOY
- VANGUARD CAPITAL MANAGEMENT LLC — $29.0K
- Tower Research Capital LLC (TRC) — $1.84K
- SBI Securities Co., Ltd. — $219
- UBS Group AG (UBS) — $180
- Caitong International Asset Management Co., Ltd — $14
Recent DCOY insider trades
- Dec 30, 2025: Hanish Arnold C sold 27 shares ($18)
- Nov 20, 2025: Hanish Arnold C bought 5,000 shares ($3.75K)
- Nov 20, 2025: Rosenblum Mark J bought 20,000 shares ($16.0K)
5%+ owners
- Armistice Capital, LLC: 10.0% (Schedule 13G, filed Aug 14, 2026)